Potential Intestinal Infection and Faecal-oral Transmission of SARS-CoV-2

Overview

Journal Nat Rev Gastroenterol Hepatol

Specialty Gastroenterology

Date 2021 Feb 16

PMID 33589829

Citations 163

Authors

Meng Guo

Wanyin Tao

Richard A Flavell

Shu Zhu

Affiliations

Soon will be listed here.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to more than 200 countries and regions globally. SARS-CoV-2 is thought to spread mainly through respiratory droplets and close contact. However, reports have shown that a notable proportion of patients with coronavirus disease 2019 (COVID-19) develop gastrointestinal symptoms and nearly half of patients confirmed to have COVID-19 have shown detectable SARS-CoV-2 RNA in their faecal samples. Moreover, SARS-CoV-2 infection reportedly alters intestinal microbiota, which correlated with the expression of inflammatory factors. Furthermore, multiple in vitro and in vivo animal studies have provided direct evidence of intestinal infection by SARS-CoV-2. These lines of evidence highlight the nature of SARS-CoV-2 gastrointestinal infection and its potential faecal-oral transmission. Here, we summarize the current findings on the gastrointestinal manifestations of COVID-19 and its possible mechanisms. We also discuss how SARS-CoV-2 gastrointestinal infection might occur and the current evidence and future studies needed to establish the occurrence of faecal-oral transmission.

Citing Articles

Wastewater surveillance of open drains for mapping the trajectory and succession of SARS-CoV-2 lineages in 23 cities of Maharashtra state (India) during June 2022 to May 2023.

Matra S, Ghode H, Rajput V, Pramanik R, Malik V, Rathore D Heliyon. 2025; 11(4):e42534.

PMID: 40040990 PMC: 11876887. DOI: 10.1016/j.heliyon.2025.e42534.

Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications.

Garcia-Rodriguez J, Janvier F, Kill C Microorganisms. 2025; 13(1).

PMID: 39858831 PMC: 11767719. DOI: 10.3390/microorganisms13010063.

Gut microbiota in post-acute COVID-19 syndrome: not the end of the story.

An Y, He L, Xu X, Piao M, Wang B, Liu T Front Microbiol. 2025; 15():1500890.

PMID: 39777148 PMC: 11703812. DOI: 10.3389/fmicb.2024.1500890.

Prolonged fecal shedding of replication-competent virus, lasting immune activation, and intestinal inflammation in a rhesus macaque after experimental SARS-CoV-2 infection.

Boszormenyi K, Stammes M, Fagrouch Z, Acar F, Niphuis H, Kayere G Front Cell Infect Microbiol. 2025; 14:1505720.

PMID: 39744155 PMC: 11688216. DOI: 10.3389/fcimb.2024.1505720.

The Intestine in Acute and Long COVID: Pathophysiological Insights and Key Lessons.

Zollner A, Meyer M, Jukic A, Adolph T, Tilg H Yale J Biol Med. 2024; 97(4):447-462.

PMID: 39703608 PMC: 11650913. DOI: 10.59249/PMIE8461.

References

Diaz L, Garcia-Salum T, Fuentes-Lopez E, Ferres M, Medina R, Riquelme A . Symptom Profiles and Risk Factors for Hospitalization in Patients With SARS-CoV-2 and COVID-19: A Large Cohort From South America. Gastroenterology. 2020; 159(3):1148-1150. PMC: 7207141. DOI: 10.1053/j.gastro.2020.05.014. View

Yuen K, Chan P, Peiris M, Tsang D, Que T, Shortridge K . Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998; 351(9101):467-71. DOI: 10.1016/s0140-6736(98)01182-9. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Alexander D . An overview of the epidemiology of avian influenza. Vaccine. 2006; 25(30):5637-44. DOI: 10.1016/j.vaccine.2006.10.051. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R . Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol. 1999; 163(1):143-7. View

Tao W, Zhang G, Wang X, Guo M, Zeng W, Xu Z . Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18. Med Microecol. 2021; 5:100023. PMC: 7832617. DOI: 10.1016/j.medmic.2020.100023. View

Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M . Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020; 69(8):1543-1544. PMC: 7211078. DOI: 10.1136/gutjnl-2020-321388. View

Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020; 5(5):434-435. PMC: 7158584. DOI: 10.1016/S2468-1253(20)30083-2. View

10.

Wu F, Zhang J, Xiao A, Gu X, Lee W, Armas F . SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases. mSystems. 2020; 5(4). PMC: 7566278. DOI: 10.1128/mSystems.00614-20. View

11.

Deng W, Bao L, Liu J, Xiao C, Liu J, Xue J . Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020; 369(6505):818-823. PMC: 7402625. DOI: 10.1126/science.abc5343. View

12.

Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr H, Hartmann G . Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol. 2001; 281(4):R1264-73. DOI: 10.1152/ajpregu.2001.281.4.R1264. View

13.

Stanifer M, Kee C, Cortese M, Zumaran C, Triana S, Mukenhirn M . Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells. Cell Rep. 2020; 32(1):107863. PMC: 7303637. DOI: 10.1016/j.celrep.2020.107863. View

14.

Papa A, Covino M, Pizzolante F, Miele L, Lopetuso L, Bove V . Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19. Eur Rev Med Pharmacol Sci. 2020; 24(13):7506-7511. DOI: 10.26355/eurrev_202007_21923. View

15.

Aghemo A, Piovani D, Parigi T, Brunetta E, Pugliese N, Vespa E . COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy. Clin Gastroenterol Hepatol. 2020; 18(10):2366-2368.e3. PMC: 7211605. DOI: 10.1016/j.cgh.2020.05.011. View

16.

Hung I, Lung K, Tso E, Liu R, Chung T, Chu M . Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020; 395(10238):1695-1704. PMC: 7211500. DOI: 10.1016/S0140-6736(20)31042-4. View

17.

Kim S, Lee J, Lee A, Kim S, Park K, Jung S . Viral Load Kinetics of SARS-CoV-2 Infection in Saliva in Korean Patients: a Prospective Multi-center Comparative Study. J Korean Med Sci. 2020; 35(31):e287. PMC: 7415999. DOI: 10.3346/jkms.2020.35.e287. View

18.

Huang K, Su I, Theron M, Wu Y, Lai S, Liu C . An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2004; 75(2):185-94. PMC: 7166886. DOI: 10.1002/jmv.20255. View

19.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

20.

Liu P, Cai J, Jia R, Xia S, Wang X, Cao L . Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19. Emerg Microbes Infect. 2020; 9(1):1254-1258. PMC: 7448895. DOI: 10.1080/22221751.2020.1772677. View